Location of Repository

Strategies for the early detection of type 2 diabetes in an at risk population

By Jennifer Ruth Tringham
Publisher: University of Leicester
Year: 2006
OAI identifier: oai:lra.le.ac.uk:2381/3838

Suggested articles

Preview

Citations

  1. 2004; 27(suppl 1):S11-S14. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus.
  2. (1996). A 12-item short form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care
  3. (2003). A calcium antagonist vs. a non-calcium antagonist hypertension treatment strategy for patients with coronary heart disease. The international VerapamilTrandolapril study (INVEST): a randomised controlled trial. JAMA
  4. (2004). A Danish Diabetes risk score for targeted screening. Inter99(6). Diabetes Care
  5. (1993). A model of early diagnosis in type 2 diabetes mellitus in primary health care. Diabet Med
  6. (1995). A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care
  7. (1992). A prospective study of exercise and incidence of diabetes among US male physicians. JAMA
  8. (1991). A prospective study of physical activity and incidence of non insulin-dependent diabetes mellitus in women. Lancet
  9. (2002). Acarbose can prevent Type 2 diabetes and cardiovascular disease in subjects with impaired glucose tolerance: The STOP-NIDDM trial. Diabetologia
  10. (2002). Acarbose for prevention of Type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet
  11. (2006). Activity Questionnaire. www.ipaq.ki.se. Accessed
  12. (1997). Adverse effects of screening for gestational diabetes: a prospective cohort study in Toronto,
  13. (2003). Age and sex specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care
  14. (1997). American Diabetes Association and 199 World Health Organization criteria for hyperglycaemia in the diagnosis and prediction of diabetes. Diabetes Care
  15. (1997). American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care
  16. (2006). and Humber Public Health Observatory.
  17. (2005). Angiotensin-Converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes.
  18. (2000). Anglo-Danish-Dutch Study of Intensive Treatment
  19. (2002). Association and National Institute of Diabetes Digestive and Kidney Diseases. The prevention or delay of type 2 diabetes. Diabetes Care
  20. (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ
  21. (2004). Association of Hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer n Norfolk. Ann Intern Med
  22. (1997). Association. Report of the Expert Committee on Diagnosis and Classification of Diabetes. Diabetes Care
  23. (2000). Association. Screening for Diabetes. A discussion document of the BDA.
  24. Association. Screening for type 2 diabetes (Position Statement) Diabetes Care 2003; 26:S221-S24. American Diabetes Association. Screening for Diabetes (position statement).
  25. (2006). Australian Expert Working Group. Case detection and Diagnosis Expert Working Group. Evidence Based Guidelines. www. nhmrc.gov.au/publications. Accessed
  26. (2004). Aventis press release: Aventis announces five year ORIGIN trial to investigate reduction in heart disease risk with LANTUS insulin,
  27. Baseline characteristics of individuals identified with prediabetes (IGT, IFG or both) through a systematic screening programme. Diabetic Medicine 2005; 22(suppl 2):98.
  28. Beliefs about diabetes and psychological predictors of the outcome of screening those at risk (STAR) of developing Type 2 diabetes. Diabetes 2003; 52(suppl 1):A419.
  29. (2006). Bias in published cost effectivenss studies: systematic review. BMJ
  30. (1999). BMJ
  31. (2006). Boey KW. Cross-validation of a short form of the CES-D in Chinese elderly.
  32. (2004). British Hypertesion Society guidelines for hypertension management
  33. (2006). Canadian Diabetes Association Website: Canadian Normoglycaemic Outcomes Evaluation Trial. www.diabetes.ca. Accessed
  34. (1989). Cardiovascular risk factors and the 25-year incidence of diabetes mellitus in middle-aged men. The Zutphen study.
  35. (1982). Cardiovascular survery methods. World Health Organization Monograph Series
  36. (2001). Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care
  37. (1997). Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Study (4S). Diabetes Care
  38. (2005). Cigarette smoking and diabetes. Diabetic Medicine
  39. (1999). Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes
  40. (1996). Clinical characteristics and follow-up of subjects with non-insulin-dependent diabetes mellitus diagnosed by screening.
  41. (1993). Community screening for noninsulin-dependent diabetes mellitus: self testing for post-prandial glycosuria.
  42. (1998). Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance. Diabetologia
  43. (1998). Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population based study in Brazil. The JapaneseBrazilian Diabetes Study Group. Diabetes Care
  44. (1993). Comparison of screening tests for non-insulin-dependent diabetes mellitus. Arch Intern Med
  45. (1994). Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ
  46. (1998). Comparison of the current WHO and new ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK. Diabet Med
  47. (1980). Coronary heart diasease risk and impaired glucose tolerance: The Whitehall study. Lancet
  48. (2006). Cost of lucozade. Accessed
  49. (1998). Cost-Effectiveness Study Group. The cost-effectiveness of screening for type 2 diabetes. JAMA
  50. (1979). Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes
  51. (1993). Deciding about screening. Ann Intern Med
  52. (1996). Developing a training programme in patient-centred consulting for evaluation in a randomised controlled trial: diabetes care from diagnosis in British primary care. Patient Educ Counts
  53. (2006). Development and progression of nephropathy
  54. (1998). Diabetes Care
  55. (1990). Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetic Metab Rev
  56. (2000). Diabetes Risk Score: towards early detection of type 2 diabetes in general practice. Diabetes Metab Res Rev
  57. (2005). Diabetes Screening Anxiety and Beliefs. Diabetic Medicine
  58. (1997). Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance:
  59. (1996). Did the intensive glycosuria screening of the sixties and seventies in East Germany improve the survival prognosis of early detected diabetics?
  60. (1996). Dysglycaemia and risk of cardiovascular disease. Lancet
  61. (1995). Early abnormalities of cardiac function in non-insulin dependent diabetes mellitus and impaired glucose tolerance.
  62. (1998). Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet
  63. (2003). Enalapril reduces the incidnece of diabetes in patients with chronic heart failure. Circulation
  64. (1986). Epidemiology of diabetes mellitus in the elderly: the Framingham study.
  65. (2005). Estimating type 2 diabetes risk: does the Cambridge risk score perform any better than body mass index? Poster presented at: Society for Social Medicine Annual Scientific Meeting,
  66. (1972). Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem
  67. (2002). Evidence based guidelines for type 2 diabetes: Case detection and diagnosis. Diabetes Australia and NHMRC
  68. (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA
  69. (2002). Fact sheet number two. www.diabetes.org.uk Diabetes UK. Position Statement. Early identification of people with type 2 diabetes.
  70. (1999). Fasting proinsulin concentrations predict the development of Type 2 diabetes. Diabetes Care
  71. (2005). Federation. IDF consensus worldwide definition of the metabolic syndrome. www.idf.org/webdata/docs/IDF _Metasyndrome_definition.pdf. Accessed
  72. (2005). Federation. IDF Diabetes Atlas – Prevalence estimates of diabetes mellitus.
  73. (1999). Feskens EJ. Performance of a predictive model to identify undiagnosed diabetes in a healthcare setting. Diabetes Care
  74. (1997). finding Diabetics – a method of screening in general practice.
  75. (2002). for Clinical Excellence. Clinical Guideline G. Management of type 2 diabetes: blood glucose.
  76. for Clinical Excellence. Guideline H. Management of type 2 diabetes. Blood pressure and lipids 2002. National Screening Committee. First report of the National Screening Committee.
  77. (1994). Frequency and determinants of screening for diabetes in the US. Diabetes
  78. (1984). Gafni A et al. Effects of labelling on income, work and social function among hypertensive employees.
  79. (2000). GHb (HbA1c) is more sensitive than fasting blood glucose as a screening test for diabetes. Letter. Diabetes Care
  80. (1998). Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projection. Diabetes Care
  81. (1986). Glucose intolerance and hypertension in North London; the Islington Survey. Diabet Med
  82. (1999). Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe. Lancet
  83. (1997). Glucose: a continuous risk factor for cardiovascular disease. Diabet Med
  84. (1997). Glycosuric tests should not be employed in population screening fro NIDDM.
  85. (1998). Group on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ
  86. (2001). group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med
  87. Health Beliefs of those with screen-detected diabetes are different to those diagnosed conventionally. Diabetic Medicine 2003; 20 (suppl 2):P79.
  88. (2004). Health. At least five a week: Evidence on the impact of physical activity and its relationship to health. A report from the Chief Medical Officer.
  89. (2003). Health. National Service Framework for Diabetes: Delivery Strategy;
  90. (2001). Health. National Service Framework for Diabetes: The Standards.
  91. (2004). Health. Quality and Outcome Framework Guidance, London, The Stationary Office.
  92. (1999). Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ
  93. (2002). Holman RR for the UKPDS Group. Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? UKPDS 61. Diabetes Care
  94. (1997). How to report statistics in medicine. 1st ed. American College of Physicians;
  95. (1976). Hyperglycaemia and diabetes mellitus. Lancet
  96. (1989). Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia
  97. (1997). Illness representations and the self-management of diabetes.
  98. (1991). Impact of late complications in type II diabetes in a Dutch population. Diabet Med
  99. (1999). Impaired fasting glucose tolerance or impaired glucose tolerance: What best predicts future diabetes in Mauritius? Diabetes Care
  100. (2003). Impaired Glucose Tolerance – Consequences and Management. Cardiabetes
  101. (2000). Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabet Med
  102. (2002). Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med
  103. (1989). Impaired glucose tolerance in the US population. Diabetes Care
  104. (1993). Insulin deficiency and increased plasma concentration of intact and 32/33 split pro-insulin in subjects with impaired glucose tolerance. Diabet Med
  105. (1976). Insulin rather than glucose homeostasis in the pathology of diabetes. Lancet
  106. (1992). Insulin resistance and cigarette smoking. Lancet
  107. (1993). Insulin resistance and insulin secretory dysfunction as precursors of non-insulin dependent diabetes mellitus. Prospective studies of Pima Indians.
  108. (1994). Insulin resistance as the major cause of impaired glucose tolerance: a self-fulfilling prophecy. Lancet
  109. (1991). Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerotic cardiovascular disease. Diabetes Care
  110. (1999). Intensified multifactorial intervention in patients with Type 2 diabetes mellitus and microalbuminuria: the Steno Type 2 randomised study. Lancet
  111. (1995). Intensive insulin therapy prevents the progression of diabetic microvascular complication in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res and Clin Pract
  112. Intensive integrated therapy of type 2 diabetes: implications for long term prognosis. Diabetes 2004; 52(suppl 3):S39-S47.
  113. (1999). International journal of geriatric psychiatry
  114. (2002). Investigators. Ramipril and the development of diabetes. JAMA
  115. (2004). Is there a psychological impact of screening for diabetes? Diabetic Medicine
  116. (1991). Knowledge of diabetes in Asians and Europeans with and without diabetes: the Coventry Diabetes Study. Diabet Med
  117. (2002). Laakso M for The STOPNIDDM Trial Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet
  118. (2005). London: Office of Population Census and Surveys,
  119. (2001). Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care
  120. (1983). Manual for State Trait Anxiety inventory. Palo Alto (CA): Consulting Psychologists Press.
  121. (1997). Meta-analysis Research Group on the diagnosis of diabetes using glycosylated hemoglobin levels. JAMA
  122. (1999). Metabolic characteristics of individuals with impaired fasting glucose tolerance. Diabetes
  123. (2003). Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: The Hoorn Screening Study. Diabetes Care
  124. (2000). More good than harm: a randomised controlled trial of the effect of the education about familial risk of diabetes on pyschological outcomes.
  125. (1983). Mortality form coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J
  126. Mortlaity from coronary heart disease in Aisan Communities in London.
  127. (2002). Mothers of children in ABIS, a population-based screening for prediabetes, experience few ethical conflicts and have a positive attitude. Ann NY Acad Sci
  128. (2003). Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
  129. (2000). National Service Framework for Coronary Heart Disease. London, The Stationary Office.
  130. (2002). Newly diagnosed type 2 diabetic population in Belgium. Diabetes Care
  131. (1999). Niklason A et al. Effect of angiotension-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomised trial. Lancet
  132. (2005). Obesity and the risk of myocardial infarction in 27 000 participants from 52 coutnries: a case-control study. Lancet
  133. (2002). Observations on the value of mass indiscriminate screening for diabetes mellitus based on a five-year follow up. Diabetes Care
  134. (1978). Observations on the value of mass indiscriminate screening for diabetes mellitus based on a five-year follow-up. Diabetes
  135. (2002). Oddone EZ. Impact of diabetes screening on quality of life. Diabetes Care
  136. (2003). Oddone EZ. Quality of care for patients diagnosed with diabetes at screening. Diabetes Care
  137. (2001). Office of Population Census and Surveys.
  138. (1992). Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care
  139. (1980). Organization: WHO Expert committee on Diabetes Mellitus. Second Report. Geneva, World Health Org.,
  140. (2003). Organization. Screening for type 2 diabetes. Report of a WHO and IDF meeting.
  141. (1999). Perceived benefits and barriers to physical activity in a nationally representative sample in the European Union. Public Health Nutrition
  142. (1997). Perceived need to alter eating habits among representative samples of adults from all member states of the European Union.
  143. (2003). Perceived risk for type 2 diabetes in participants in a stepwise populationscreening programme. Diabet Med
  144. (1997). Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care
  145. (2005). Performance of Screening Questionnaires and risk Scores for Undiagnosed Diabetes. Arch Intern Med
  146. (2004). Performance of the glucose tolerance test in a diabetes screening study. Diabetic Medicine
  147. (2002). personal model beliefs, and self-care in adolescents and young adults with type 1 diabetes. Health Psychol
  148. (1995). Physical activity and incidence of diabetes: the Honolulu Heart Program.
  149. (1997). Plasma glucose and prediction of microvascular disease and mortality: evaluation of
  150. (2005). Population Trends Autumn.
  151. (2004). Population-based stepwise screening for unrecognised type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia
  152. (2001). Pravastatin and the development of diabetes mellitus: evidence for a protective effect in the West of Scotland Coronary Prevention Study. Circulation
  153. Presence of complications of diabetes in individual with screen-detected type 2 diabetes. Diabetic Medicine 2005; 22(suppl 2):100. Tringham
  154. (2002). Preservation of pancreatic B-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes
  155. (1989). Prevalence of diabetes in a predominantly Asian community: preliminary findings of the Coventry diabetes study. BMJ
  156. (1998). Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care
  157. (2005). Prevalence of undiagnosed type 2 diabetes and impaired fasting glucose in older British men and women. Diabet Med
  158. (2000). Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet
  159. (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
  160. (1991). Prevention of type 2 diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia
  161. (2004). Prevention of Type 2 diabetes mellitus. A review of the evidence and its application in a UK setting. Diabet Med
  162. (2004). Prevention of type 2 diabetes mellitus. A review of the evidence and its application in a UK setting. Diabetic Medicine
  163. (1999). Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischaemic stroke. The Atherosclerosis Risk in communities (ARIC) Study investigators. Diabetes Care
  164. (1998). Prospective Diabetes Study Group (UKPDS). Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications inpatient with type 2 diabetes. (UKPDS 33). Lancet
  165. (1995). Prospective Diabetes Study Group. Overview of six years' therapy of type 2 diabetes - a progressive disease. UKPDS 16. Diabetes
  166. (1998). Prospective Study Group (UKPDS). Tight blood pressure control and risk of macrovascular and microvascular outcomes in people with diabetes: UKPDS 38. BMJ
  167. (1995). Prospective study of cigarette smoking, alcohol use and the risk of diabetes in men. BMJ
  168. (1995). Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ
  169. (2005). Public Health Observatory. www.empho.org.uk/products. Accessed
  170. (1995). Random capillary whole blood glucose test as a screening test for diabetes mellitus in a middle aged population.
  171. (1997). Randomised Controlled Trial of Reinforced Healthy-Living Advice in Subjects with Increased but not Diabetic Fasting Plasma Glucose. Metabolism
  172. (2001). Randomized controlled trial to assess the psychological impact of a family history screening questionnaire in general practice. Family Practice
  173. (2003). Recent Advances in interventions for Impaired Glucose Tolerance. Practical Cardiovascular Risk Management
  174. (2001). Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA
  175. (2003). Reliability and Validity of the Diabetes Illness Representations Questionnaire: Four Studies with Adolescents. Diabet Med
  176. (2004). Remission to normoalbuminuria during mulitfactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. Nephrology Dialysis Transplantation
  177. (2001). Risk and prevention of type 2 diabetes: offspring’s views.
  178. (1996). risk factors and prognostic implications of albuminuria in NIDDM. Diabetes Care
  179. (1998). Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus:
  180. (1996). Risk factors for myocardial infarction and death in newly detected NIDDM: The Diabetes Intervention Study (DIS), 11-year follow-up. Diabetologia
  181. Risk factors for screening for type 2 diabetes are different in South Asians and White Europeans: implications for screening strategies. Diabetic Medicine 2005; 22(suppl 2):99.
  182. (1979). Risk factors other than hyperglycaemia in diabetic macrovascular disease. Diabetes Care
  183. (1999). Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. Diabetes Care
  184. (2002). Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
  185. (1988). Role of insulin resistance in human disease. Diabetes
  186. (2006). Screening Committee. National Screening Committee Policy and Screening Documents. www.nsc.nhs.uk. Accessed
  187. (2001). Screening for diabetes in general practice: a cross sectional population study. BMJ
  188. (1998). Screening for diabetes: what are we really doing? BMJ
  189. (2004). Screening for IGT and diabetes.
  190. (1994). Screening for non-insulin dependent diabetes mellitus: how often should it be performed? J Med Screening
  191. (2004). Screening for type 2 diabetes and impaired glucose metabolism. The Australian Experience. Diabetes Care
  192. (1999). Screening for type 2 diabetes mellitus in the UK Indo-Asian population. Diabet Med
  193. (2004). Screening for type 2 diabetes mellitus: a cost-effectiveness analysis. Ann Intern Med
  194. (2002). Screening for type 2 diabetes: and exploration of subjects’ perceptions regarding diagnosis and procedure. Diabet Med
  195. (2000). Screening for type 2 diabetes. Diabetes Care
  196. (1995). Screening fro diabetes mellitus in adults. The utility of random capillary blood glucose measurements. Diabetes Care
  197. (2003). Screening those at risk: study design and recruitment. Diabetic Medicine 2003; 20(suppl 2):P68.
  198. (2003). Secondary prevention of cardiovascular events with long term pravastatin in patients with diabetes or impaired fasting glucose. Diabetes Care
  199. (1971). Sensitivity and specificity of five screening tests for diabetes in ten countries. Diabetes
  200. (2003). Services Task Force. Screening for Type 2 Diabetes Mellitus in Adults: Recommendations and Rationale. Ann Intern Med
  201. (2001). Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. BMJ
  202. (2003). Six-year results from the Early Diabetes Intervention Trial. Diabet Med
  203. Societies. Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91(suppl 5):1-52. Julius
  204. (2006). Society. www.bhsoc.org/guidelines. Accessed
  205. (2003). Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized placebo-controlled trial. Lancet
  206. Systematic screening for type 2 diabetes mellitus: results of a large population based study targeting those with conventional risk factors. Diabetic Medicine 2005; 22(suppl 2):99.
  207. (1980). Ten-year follow-up of subjects with impaired glucose tolerance. Prevention of diabetes by tolbutamide and diet regulation. Diabetes
  208. (1999). The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men.
  209. (1991). The Big Five Inventory: Versions 4a and 54 (technical report).
  210. (1999). The British Diabetic Assoication Cohort Study II. Cause specific mortality in patient with insulin treated diabetes mellitus. Diabet Med
  211. The CES-D scale: A self report depression scale for research in the general population. Applied psychiatric measurement 1977; 1:385-401. Ramachandran
  212. (1991). The Coventry Diabetes Study: Prevalence of diabetes and impaired glucose tolerance in Europids and Asians. QJM
  213. (1992). The development of a six-item short form of the Spielberger state-trait anxiety inventory (STA).
  214. (2000). The Diabetes Prevention Program Research Group. Baseline characteristics of the randomized cohort. Diabetes Care
  215. (2002). The Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes With Lifestyle Intervention or Metformin.
  216. (2003). The diabetes risk score: a practical tool to predict type 2 diabetes. Diabetes Care
  217. (1985). The disposal of an oral glucose load in normal subjects. A quantitative study. Diabetes
  218. The effectiveness of fasting plasma glucose and HbA1c in screening for type 2 diabetes in South Asians and White Europeans in Leicestershire, United Kingdom. Diabetes 2004; 52(suppl 2):A529.
  219. (1999). The Funagata Diabetes Study. Impaired Glucose Tolerance Is a Risk Factor for Cardiovascular Disease, but Not Impaired Fasting Glucose. Diabetes Care
  220. (1987). The glycohaemoglobin assay as a screening test for diabetes mellitus. The Islington Diabetes Survey. Diabet Med
  221. (1998). The Illness Perception Questionnaire: A new method for assessing the cognitive representation of illness.
  222. (1993). The impact of cigarette and alcohol consumption on weight and obesity. An analysis of 1911 monozygotic male twin pairs. Arch Intern Med
  223. (2003). The impact of screening for type 2 diabetes in siblings of patients with established diabetes. Diabet Med
  224. (1998). The Independent Inquiry into Inequalities in Health Report.
  225. (1994). The mortality of elderly people with diabetes. Diabet Med
  226. (1997). The Nurses’ Health Study.
  227. (2004). The performance of a risk score as a screening test for undiagnosed hyperglycaemia in ethnic minority groups: data from the 1999 health survey for England. Diabetes Care
  228. (2002). The performance of a risk score in predicting undiagnosed hyperglycaemia. Diabetes Care
  229. The prevalence of the metabolic syndrome in patients with screen detected abnormal glucose tolerance. Diabetologia 2004; 47(suppl 1):
  230. (1996). The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?
  231. (1999). The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care
  232. (1997). The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med
  233. (2002). The rising prevalence of diabetes mellitus and impaired glucose tolerance: the Australian diabetes, obesity and lifestyle study. Diabetes Care
  234. (1983). The role of circulating glucose and triglyceride concentrations and their interactions with other ‘risk factors’ as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study. Diabetes Care
  235. (1985). The Southall Diabetes Survey: Prevalence of known diabetes in Asians and Europeans. BMJ
  236. (1982). The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes. Diabetologia
  237. (1992). The use of portable blood glucose monitors by trained lay operators.
  238. (1999). The use of risk factor scoring method in screening for undiagnosed diabetes in the genral population. Chung Hua Liu Hsing Ping Hsuea Tas Chih
  239. (1977). Treatment of borderline diabetes: controlled trial using carbohydrate restriction and phenformin. BMJ
  240. (1994). UK Prospective Diabetes Study 12; Differences between Asian, Afro-Caribbean and white Caucasian type 2 diabetic patients at diagnosis of diabetes. Diabet Med
  241. (1997). Undiagnosed diabetes or impaired glucose tolerance and cardiovascular risk. Diabetes Care
  242. (1993). Undiagnosed NIDDM: clinical and public health issues. Diabetes Care
  243. (1999). Use of a questionnaire for screening people with undiagnosed diabetes. Rev Inves Clin
  244. Use of the 1997 American Diabetes Association diangostic criteria for diabetes in a Hong Kong Chinese population.
  245. (2005). Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance. Diabetes Care
  246. (2005). Utility of Risk Factors when Screening for Diabetes Mellitus. Diabetes
  247. Validity of the five-item WHO WellBeing Index (WHO-5) in an elderly population. European archives of psychiatry and clinical neuroscience 2001; 251(suppl 2):II27-31.
  248. (1979). Worsening to diabetes in men with impaired glucose tolerance. Diabetologia
  249. (2002). www.diabetes.org. Accessed

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.